Immunopathology Core
Immunopathology Core
批准号:
10628215
负责人:
Rudragouda Channappanavar
金额:
$13.01万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-05 至 2028-06-30
关键词:
AnatomyAnimalsAreaAwarenessBiomedical ResearchCell SeparationCellsCenters of Research ExcellenceCollaborationsCommunicable DiseasesCommunitiesComparative StudyComplexCore FacilityDataDevelopmentElementsExtramural ActivitiesFee-for-Service PlansFeesFlow CytometryFluorescence-Activated Cell SortingFoundationsFundingGoalsGrantGrowthHistologicHistopathologyHuman ResourcesImmune System DiseasesImmunoassayImmunofluorescence ImmunologicImmunohistochemistryImmunologicsImmunologyImmunology procedureIn VitroIncentivesInfrastructureInstitutionInternationalLaboratoriesLesionOklahomaPathogenesisPathologicPathologyPhasePilot ProjectsResearchResearch DesignResearch PersonnelResearch Project GrantsResearch SupportResourcesRespiratory CenterRespiratory DiseaseScientistServicesSystemTechnologyTissue ModelTissuesTrainingassay developmentcell analyzerdata curationexperienceimmunopathologyin vivoinstrumentationoutreachoutreach programprogramsrecruitservice programssuccesssymposiumtissue processinguser-friendlyvoucher
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Immunopathology Core
Project Summary
Biomedical researchers are often limited in their ability to perform complex immunopathologic analyses, either
by a lack of technology/instrumentation available or by inexperience in delineating complex mechanisms
associated with immune dysfunction and disease pathogenesis. The Immunopathology Core Laboratory (IPC)
program in the Oklahoma Center of Respiratory and Infectious Diseases (OCRID) bridges this gap and provides
a comprehensive solution by providing (1) access to cutting-edge assays for immunological data curation, (2)
tissue processing for histopathology and downstream immunologic assays, and (3) expert support in the
analyses of immunopathologic data and gross/histologic lesion interpretation. At its core, the IPC functions as a
critical resource for pilot projects and OCRID investigators by providing flow cytometry, fluorescent-assorted cell
sorting (FACS), immunofluorescent immunohistochemistry (IFA-IHC), and multiplex immunoassay (MIA)
analyses. These functions are augmented through integration of our histopathology unit, which provides
essential support in processing of research tissues for pathologic interpretation and downstream immunologic
analyses. The primary function of the IPC in Phase III of this will be to provide continued immunology and
pathology support for COBRE pilot projects and OCRID Center Investigators through implementation of a
voucher program. The immediate impacts of the IPC in Phase III will be to (1) sustain OCRID pilot projects and
investigators by facilitating access to immunopathologic services, and (2) continue development of OCRID by
providing the means to incentivize growth of OCRID programs and projects beyond Phase III. The long-term
goal of this Phase III project will be to broaden and diversify the IPC to recruit investigators from wider research
fields from supporting institutions, thereby instituting a long-term solution for researchers in the region. To
achieve this, the IPC will capitalize on the momentum gained by our fee-for-service program to expand services
and capabilities to serve a larger group of scientists in the regional research community through (1) outreach
seminars to increase awareness across the region, (2) soliciting collaborative extramural grant collaborations to
recruit projects that utilize core services, and (3) acquisition of a user-friendly, high throughput cell analyzer to
facilitate usage by wider clientele. We have already taken steps to increase usage by OCRID investigators and
researchers at other institutions and by implementing outreach programs to increase our profile and build intra-
and extramural clientele within the region, we will expand the IPC into a self-sustaining entity, able to support
current and long-term state-of-the-art research projects at local and regional institutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 4: Inflammatory monocyte-macrophages in age-related susceptibility to SARS-CoV-2 infection
-
批准号:10654149
-
项目类别:
-
资助金额:$18.53万
-
财政年份:2022
-
负责人:Rudragouda Channappanavar
-
依托单位:
Role of interferon lambda in host protection during aging
-
批准号:9764228
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2018
-
负责人:Rudragouda Channappanavar
-
依托单位:
Immunopathology Core
-
批准号:10459261
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2013
-
负责人:Rudragouda Channappanavar
-
依托单位:
海外基金